This investigation aims to elucidate the effects of HKC in ameliorating renal injury in DN and to demonstrate that modulating the Keap1/Nrf2/HO-1 pathway and the 5-HT pathway may play an important role in DN treatment. This evidence concerns the gene KEAP1 and liver dysplastic nodule.